Login / Signup

Primary Norfloxacin Prophylaxis for APASL-Defined Acute-on-Chronic Liver Failure: A Placebo-Controlled Double-Blind Randomized Trial.

Anand V KulkarniSowmya TirumalleMadhumita PremkumarKaran KumarSyeda FatimaBindu RapoleVenu SimhadriBaqar Ali GoraMitnala SasikalaDeepika GujjarlapudiSadhana YelamanchiliMithun SharmaRajesh GuptaPadaki Nagaraja RaoD Nageshwar Reddy
Published in: The American journal of gastroenterology (2022)
Primary norfloxacin prophylaxis effectively prevents bacterial infections in patients with ACLF.
Keyphrases
  • liver failure
  • placebo controlled
  • double blind
  • hepatitis b virus
  • clinical trial
  • phase iii
  • study protocol
  • phase ii
  • squamous cell carcinoma
  • drug induced
  • radiation therapy
  • mouse model
  • respiratory failure